IGHID: Clinical Trials Unit
In the News
-
Supporting People Living With HIV In Vietnam
Clinical Trials Day honors all that has been accomplished through clinical trials, as well as the people behind them. The UNC Global Clinical Trials Unit at the Institute for Global Health and Infectious Diseases (IGHID) facilitates high-quality research, with investigators and research coordinators working to address the challenging questions that need answers, that impact the lives … Read more
-
UNC Global Clinical Trials Unit Launches New HIV Drug Combination For Enhancing Immune Response and Suppression
The Institute for Global Health and Infectious Disease’s Global Clinical Trials Unit attracts leading trials from national feeder networks to study treatment innovations that can advance health. A new HIV study with the ACTG will evaluate the safety, tolerability, and antiviral effect of a novel combination regimen that includes therapeutic T-cell vaccines, two broadly neutralizing … Read more
-
UNC Global Clinical Trials Unit Launches HPTN 102: HIV Prevention Study for Cisgender Women
Despite a decline in HIV incidence in women in the U.S., approximately 18% of new HIV diagnoses in 2021 were among women. Meanwhile, many cisgender women have not considered HIV PrEP (pre-exposure prophylaxis) as an option for themselves when it comes to HIV prevention. Historically, studies of interventions to prevent sexually transmitted infections have excluded … Read more
-
Long Covid Is Real: Researchers Seek Participants for NIH Study Trial During Long Covid Awareness Month
March is Long COVID Awareness Month, marking four years since COVID-19 was declared a pandemic. But while much of society has moved on from masking, quarantining, and isolating, there are many who are managing health problems long after having COVID-19. Researchers at the Institute for Global Health and Infectious Diseases are participating in the NIH Phase 2 Recover-Vital trial to … Read more